In research people are your true strength and at the Florey, our staff are encouraged to follow their passion with rigour. Our 600 staff and students working collaboratively make the Florey Australia's foremost brain research centre and one of the largest internationally.
Our new facilities will allow us to expand our scientific reach. Through our scientific vision we have recognised our research strengths and are looking to expand into new areas of neuroscience.
The Florey team is made up of world leaders in epilepsy, stroke, imaging, stem-cell research, Parkinson’s disease and many others. We attract experts from all over the world and we are looking for more.
To learn more about our leadership group and senior staff, click on the links below.
Board of Directors
Mr Harold Mitchell AC (Chairman)
Mr Harold Mitchell is the founder of Mitchell & Partners and until August 2013 was the Executive Chairman of Aegis Media Australia and New Zealand. Mitchell & Partners is the largest media and communication group in Australia, with growing presence in New Zealand and across the Asia-Pacific region. Mr Mitchell holds a large number of community roles including; Chairman of Arts Exhibitions Australia; Chairman Free TV Australia; Vice President of Tennis Australia; Director of New York Philharmonic, Chairman, Premier’s Job and Investment Panel Chairman Australia – Indonesia Centre and a Director of Crown Ltd. He has also been Chairman of CARE Australia; Chairman of the National Gallery Australia; President of the Melbourne International Festival of Arts; President of the Museums Board of Victoria and a Board member of the Opera Australia Council. Mr Mitchell was appointed Companion of the Order of Australia in 2010 for eminent service to the community through leadership and philanthropic endeavours in the fields of art, health and education and as a supporter of humanitarian aid in Timor-Leste and Indigenous communities. In 2013 Mr Mitchell was awarded the Victorian of the Year.
Mr Andrew Abercrombie, BEc LLB MBA (IMD)
Mr Andrew Abercrombie is the founding Director of FlexiGroup Limited (FXL) and remains on the FlexiGroup Board continuing to work with the CEO and management team. FXL is a now a top 150 company on the ASX. Formerly a commercial lawyer, he oversees a broad range of commercial interests. He was the Regional Chairman of the World Presidents’ Organisation and continues to participate in international education programs in various roles. Formerly a member of one of Victoria’s Alpine Resort Management Boards, he is also a Director of the Menzies Research Centre, the Melbourne Zoo Foundation and Treasurer of the Liberal Party of Australia (Victorian Division).
Mr Craig Drummond, B.Comm (Melb) ACA SFFIN
Mr Craig Drummond is the Chief Executive Officer of Medibank Private. Prior to this, Craig was with the National Australia Bank as Group Executive, Finance & Strategy and was appointed Chairman of the JBWere Board in July 2014. Before joining NAB, Craig spent four years as Chief Executive and Country Head of Bank of America Merrill Lynch Australia. Prior to that, Craig joined Goldman Sachs JB Were in 1986 and held various roles including Chief Operating Officer, Chief Executive Officer and Executive Chairman. Craig is a Board member of The Geelong Football Club and a member of The Ian Potter Foundation Finance Committee. Craig is a Senior Fellow of FINSIA and a Chartered Accountant.
Emeritus Professor Andrea Hull AO, BA Dip Ed (Univ of Sydney) MBA (MBS, Univ of Melb) Hon Doc (Univ of Melb) FAICD FAIM
Professor Andrea Hull has had a distinguished career in CEO and executive roles, and also as a non-executive Board member in government and not-for-profit organisations. She is an Emeritus Professor at the University of Melbourne, and is Chair of ABC Advisory Council, recent Deputy Chair of the Breast Cancer Network of Australia and recent Deputy Chair of the National Museum of Australia. She is also a Board member of The Melbourne Forum, and The Melbourne Prize. Professor Andrea Hull has undertaken numerous international and national assignments, and served on many international, federal and state bodies to advance the integration of economic, social and cultural agendas.
Mr Mark Jones AM, BA (Hons) (Sheff) MBA (MBS) FCA FCPA FAICD FCA (UK) MIIA (Aust)
Mr Mark Jones is the Ethics and Independence Partner and the Chief Operating Officer of the Risk Management Group at KPMG. He also provides professional services in the areas of board advisory, corporate governance, internal audit and risk management. Mr Jones is the Chairman of the Jigsaw Foundation, which recently raised $15.3 million to endow “The Jigsaw Foundation Chair of Paediatric Plastic and Maxillofacial Surgery” at the University of Melbourne, which is based at the Royal Children’s Hospital.
Mr Stephen Spargo AM, LLB LLM
Mr Stephen Spargo is a former partner and now consultant of Allens, a leading Australian law firm. He is Chairman of The Royal Agricultural Society of Victoria Limited, a Vice‑President of the Melbourne Cricket Club, Vice‑President of Golf Victoria, a director of the Committee for the Economic Development of Australia and a Director of the Foundation for Australia‑Japan Studies Limited.
Professor James Angus AO, FAA FAHMS (Hon) BSc PhD
James Angus is former Dean of the Faculty of Medicine, Dentistry and Health Science at the University of Melbourne. He is also a Fellow and former Member of Council at the Australian Academy of Science. He is currently Honorary Professor of Pharmacology at the University of Melbourne, a Director of The Peter MacCallum Cancer Centre, Director of The Jack Brockhoff Foundation and President National Stroke Foundation. Professor Angus is the Vice Chancellor’s nominee for appointment in accordance with the Constitution and was previously a non-executive Director of The Mental Health Research Institute (appointed 2003). He was appointed an Officer of The Order of Australia in 2010 for distinguished service to biomedical research, particularly in the fields of pharmacology and cardiovascular disease, as a leading academic and medical educator, and as a contributor to a range of advisory boards and professional organisations, both nationally and internationally.
Ms Lyndsey Cattermole AM, BSc FACS
Ms Cattermole was the founder and managing director of Aspect Computing, the largest Australian software and services organisation. She also spent many years at the Royal Children’s Hospital, AS Vice President and inaugural Chairman for the Women’s and Children’s Health Care Network. Ms Cattermole was also instrumental in forming the Murdoch Children’s Research Institute. Ms Cattermole has also been at the forefront of the IT Industry, including the Australian Computer Society, the Prime Minister’s Science and Engineering Council, the Federal Government Electronic, Electrical and Information Industry Board, the Multimedia Advisory Committee, State Development Committee and The Premier’s Business Round Table. She is currently a Board Member of Treasury Wine Estates, Tatts Group, PACT Group, the Melbourne Theatre Company, Melbourne Rebels Rugby Union and immediate past Chairman of MLC.
Mr Ross Oakley OAM, MBA
Mr Oakley is well known to many Victorians who, as the Chairman and CEO of the troubled Victorian Football League back in 1986, transformed the game to become an Australian competition. In 2009, Mr Oakley was inducted into the AFL Hall of Fame. His career includes management of insurance companies, including AAMI, and as CEO of Royal Insurance. He was the CEO of the Melbourne Rebels in 2010 during a time of tumultuous change. Mr Oakley holds an MBA from the Melbourne Business School and is a former Adjunct Professor at Deakin University’s Faculty Business and Law where he also lectured. Mr Oakley is the Chairman of the Florey’s Foundation Board, overseeing fundraising with a dedicated group of high-powered volunteers from the business sector.
Professor Geoffrey Donnan AO, MBBS MD FRACP FRCP (Edin) FAHMS
Director of The Florey Institute of Neuroscience and Mental Health and Professor of Neurology, The University of Melbourne. His major interests are in neuroimaging and clinical trials. He was co-founder of the Australian Stroke Trials Network (ASTN) and Neuroscience Trials Australia (NTA). He is Past-President of the World Stroke Organization. He received the American Stroke Association William Feinberg Award for Excellence in Clinical Stroke Research in 2007, the Swedish Karolinska Institute Award for Excellence in Stroke Research and the World Stroke Organization Leadership in Stroke Medicine Award in 2012 and the European Stroke Congress Wepfer Award for stroke research in 2014.
NOTABLE PAST BOARD MEMBERS AND THEIR CURRENT POSITIONS
Professor Anne Kelso AO (Resigned 2015) BSc (Hons) Ph D (Melb)
Professor Kelso is the Chief Executive Officer (CEO) of NHMRC. She was previously Director of the WHO Collaborating Centre for Reference and Research on Influenza in Melbourne, a role she held from 2007 until early 2015. Her earlier research career was spent at the Swiss Institute for Experimental Cancer Research, the Walter and Eliza Hall Institute of Medical Research and the Queensland Institute of Medical Research, where she earned her reputation as a leading researcher in the field of immunology. From 2000 until 2006, she was also Director/CEO of the Cooperative Research Centre for Vaccine Technology.
She has previously served as President of the Australasian Society for Immunology, as Secretary-General of the International Union of Immunological Societies and as a member of several governing boards and advisory groups, including the Council of QUT, the Boards of the Telethon Kids Institute and committees advising the WHO and the Australian Government on influenza. She was appointed Officer in the Order of Australia in June 2007 for service to science.
Dr Brendan Murphy (Resigned 2016) MBBS PhD FRACP FAICD FAHMS FCHSM (Hon)
Dr Brendan Murphy is the new Chief Medical Officer for the Commonwealth. He takes up the position on October 4. Previously, Dr Murphy was Chief Executive Officer of Austin Health for 11 years.. Prior to that, he was Professor/Director of Nephrology and Chief Medical Officer at St. Vincent’s Health. He is President of the Victorian Hospitals Industrial Association and is also a Director of the Olivia Newton-John Cancer Research Institute, a Professorial Fellow with the title of Professor at Melbourne University and a Fellow of the Australian Academy of Health and Medical Sciences.
Dr Alan Finkel AO FTSE, PhD Eng
Dr Alan Finkel is Australia’s Chief Scientist. Alan has an extensive science background as an entrepreneur, neuroscientist and educator. Prior to becoming Chief Scientist, he was the Chancellor of Monash University and President of the Australian Academy of Technology and Engineering (ATSE). Dr Finkel was awarded his PhD in electrical engineering from Monash University and worked as a postdoctoral research fellow in neuroscience at the Australian National University. In 1983 he founded Axon Instruments, a California-based, ASX-listed company that made precision scientific instruments used at pharmaceutical companies and universities for the discovery of new medicines. After Axon was sold in 2004, Dr Finkel became a director of the acquiring company, NASDAQ-listed Molecular Devices. He is a former Board member of the National Stroke Research Institute and played a crucial role in a successful amalgamation that formed the Florey Neuroscience Institutes.
Professor Ross Bathgate (Neuropeptides), BSc (Hons) PhD
Professor Philip Beart (co-head, Neurodegeneration), PhD, ANU, DSc Melbourne
Professor Julie Bernhardt (Stroke)
Associate Professor Amy Brodtmann (Behavioural Neuroscience), MBBS FRACP PhD
Professor Alan Connelly (Imaging), PhD
Professor Brian Dean (Biological Psychiatry and Mental Health)
Professor Graeme Jackson (Epilepsy), BSc (Hons) MBBS FRACP MD
Professor Trevor Kilpatrick (Multiple Sclerosis), MBBS PhD FRACP
Professor Andrew Lawrence (Behavioural Neuroscience), BSc (Hons) PhD (Loughborough)
Professor Colin L Masters MD (co-head, Neurodegeneration)
Professor Robin McAllen (Systems Neurophysiology), BSc PhD MB ChB
Professor Steven Petrou (Epilepsy), BSci (Hons) PhD
Professor Seong-Seng Tan (Brain Development & Regeneration), BDS (Mal) MDS (Adel) DPhil (Oxon) FRACDS
David Abbott (Epilepsy Neuroinformatics Laboratory)
Paul Adlard (Synaptic Neurobiology Laboratory)
Timothy Aumann (Adult Neurogenesis Laboratory)
Kevin Barnham (Neurotherapeutics Laboratory)
Ross Bathgate (Neuropeptide Receptor Group)
Phil Beart (Cellular Neurodegeneration Laboratory)
Wah Chin Boon (Steroid Neurobiology Laboratory)
Amy Brodtmann (Clinical Neuroscience Group)
Ashley Bush (Oxidation Biology Laboratory)
Dominique Cadilhac (Public Health and Health Services Research Group)
Fernando Calamante (MRI Blood Flow and Brain Connectivity Laboratory)
Leeanne Carey (Neurorehabilitation and Recovery Group)
Robert Cherny (Prana Laboratory)
Steven Collins (Creutzfeldt Jakob Disease Clinical Research Group)
Alan Connelly (Advanced MRI Development Group)
Jeannette Davies (Glia Research Laboratory)
Stephen Davies (Spinal Research Laboratory)
Brian Dean (Molecular Psychiatry Laboratory)
Simon Drew (Biophysics Laboratory)
Jhodie Duncan (Inhalant Addiction Laboratory)
Mathias Dutschmann (Respiratory Neurophysiology Laboratory)
David Finkelstein (Pre-clinical Parkinson's Disease Research Laboratory)
Andrea Gogos (Hormones in Psychiatry Laboratory)
Ben Gu (Innate Phagocytosis Laboratory)
Andrew Gundlach (Peptide Neurobiology Laboratory)
Anthony Hannan (Neural Plasticity Laboratory)
Dominic Hare (Analytical Neurochemistry Development Group)
Rachel Hill (Psychoneuroendocrinology Laboratory)
Malcolm Horne (Parkinson's Disease Laboratory)
Akhter Hossain (Insulin Peptides Group)
Jason Howitt (Protein Trafficking and Signalling Laboratory)
Graeme Jackson (Epilepsy Imaging Laboratory)
Trevor Kilpatrick (Neuroimmunology and Remyelination Laboratory)
Jee Hyun Kim (Developmental Psychobiology Laboratory)
Andrew Lawrence (Addiction Neuroscience Laboratory)
Clive May (Neurocardiovascular Laboratory)
Robin McAllen (Autonomic Neuroscience Laboratory)
Gawain McColl (Molecular Gerontology Laboratory)
Paul McCrory (Traumatic Brain Injury Laboratory)
Stuart McDougall (Vicerosensory Laboratory)
Jess Nithianantharajah (Synapse Biology and Cognition Laboratory)
Lucy Palmer (Neural Networks Laboratory)
Clare Parish (Stem Cells and Neural Development Laboratory)
Steven Petrou (Ion Channels and Human Diseases Laboratory)
Christopher Reid (Neurophysiology of Excitable Networks Laboratory)
Thibault Renoir (Genes Environment and Behaviour Laboratory)
Blaine Roberts (Neuroproteomics and Metalloproteomics Laboratory)
Ingrid Scheffer (Epilepsy Research Centre)
Daniel Scott (Receptor Structure and Drug Discovery Laboratory)
Suresh Sundram (Molecular Psychopharmacology Laboratory)
Christopher Tailby (Epilepsy Cognition Laboratory)
Seong-Seng Tan (Exosome Biology Laboratory)
Lachlan Thompson (Neurogenesis and Neural Transplantation Laboratory)
Bradley Turner (Motor Neuron Disease Laboratory)
John Wade (Peptide and Protein Chemistry Laboratory)
Song Yao (Neurovascular Biology Laboratory)
Senior Administrative Staff
Professor Geoffrey Donnan AO (Scientific Director), MBBS MD FRACP FRCP (Edin)
Dr Henry De Aizpurua (Deputy Director)
Professor Steve Petrou (Deputy Director), BSci (Hons) PhD
Professor Graeme Jackson (Deputy Director), BSc (Hons) MBBS FRACP MD
Professor Alan Connelly (Associate Director), PhD
Professor Andrew Lawrence (Associate Director), BSc (Hons) PhD (Loughborough)
Mr Peter Plecher (Group Director Finance), BBus, CA, MAICD
Mr Rodi Neri (Group Human Resources Manager)
Ms Jane Standish (Manager, Fundraising and Marketing), BBus(Mktg), CPM, FIA
Ms Amanda Place (Corporate Communications, media and philanthropy)
Mr Tim Brewer (ICT Group Manager), BSc(CompSc), BA, MACS CP